Tesofensine

Also known as: NS2330

Overview

Tesofensine is an SNDRI that modulates dopamine, serotonin, and norepinephrine to suppress appetite, enhance metabolism, and elevate mood. Initially tested for Parkinson’s and Alzheimer’s; now studied for obesity.

Benefits

- Weight loss

- Metabolic enhancement

- Cognitive improvement

Consider This Peptide If You Want To

- Suppress appetite and improve metabolism

- Support mood, focus, and energy

Dosage & Administration

Dosage Guidelines

Recommended Dosage

• Amount:0.5 mg

• Frequency:daily

• Duration:12 weeks

• Rest Period:12 weeks

• Time of Day:morning

• Ingestion:oral

Administration Routes:Oral

Research Findings on Dosage:

Capsule/Tablet Form:

• Commonly Reported Dosage: 0.5 mg (1 tablet) to 1 mg (2 tablets) daily

• Duration: 12-24 weeks

Mechanism of Action

Mechanism of Action

How this peptide works in the body

Neurotransmitter Reuptake Inhibition:

Tesofensine inhibits serotonin (SERT), norepinephrine (NET), and dopamine (DAT) transporters, preventing reuptake and increasing synaptic concentrations of these neurotransmitters. This enhances neurotransmission in the hypothalamus, limbic system, and prefrontal cortex, modulating appetite, mood, and reward-based behaviors.

Serotonin-Mediated Satiety:

Elevated serotonin (5-HT) levels activate 5-HT2C receptors in the hypothalamic arcuate nucleus, stimulating pro-opiomelanocortin (POMC) neurons while inhibiting neuropeptide Y (NPY) and agouti-related peptide (AgRP) neurons. This suppresses hunger signals, prolongs satiety, and reduces caloric intake.

Norepinephrine-Induced Thermogenesis:

Increased norepinephrine (NE) signaling activates β-adrenergic receptors (β3-AR) in brown adipose tissue (BAT), stimulating uncoupling protein 1 (UCP1)-mediated thermogenesis and lipolysis. This enhances basal metabolic rate (BMR) and promotes fat oxidation for energy production.

Dopamine-Driven Reward Regulation:

Elevated dopamine (DA) levels enhance signaling in the mesolimbic reward pathway (ventral tegmental area to nucleus accumbens), reducing hedonic eating and food cravings. Increased DA transmission also improves motivation, focus, and cognitive function, supporting long-term adherence to dietary changes.

Consider Stacking With

- Semaglutide/Tirzepatide

- NAD+

Side Effects & Cautions

Common Side Effects

- Insomnia, restlessness

- Mild anxiety

Cautions

- Elevated HR/BP

- Serotonin syndrome risk with SSRIs/MAOIs

- Avoid during pregnancy or in psychiatric conditions

Research & References

Research Highlights

Weight Loss Studies:

Clinical trials revealed significant reductions in body weight, body fat percentage, and waist circumference over a 6-month period.

Demonstrated a pronounced impact on appetite suppression and a modest effect on increasing energy expenditure.

Neurotransmitter Modulation:

Improves the balance of dopamine, serotonin, and norepinephrine, which are integral to mood regulation and appetite control.

Cognitive and Energy Benefits:

Originally investigated for cognitive enhancement in neurodegenerative diseases, tesofensine supports mental focus and physical vitality.

References

Astrup A., et al. "Tesofensine: A novel potent appetite suppressant for the treatment of obesity." International Journal of Obesity. 2008

Halford J.C., et al. "Neurotransmitter modulation and weight loss efficacy of tesofensine in obesity management." Clinical Pharmacology & Therapeutics. 2020

Simonsen K.L., et al. "Effects of tesofensine on cognitive function and metabolic health." Neuropsychopharmacology. 2019

Silva A.R., et al. "Safety and efficacy of tesofensine in weight management: A randomized clinical trial." Journal of Obesity Medicine. 2022